Seroatlas · Human Serome Atlas

AZIN1

Antizyme inhibitor 1

Also known as: AZIN1_HUMAN, OAZI, OAZIN, ODC1L

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O14977
Gene
AZIN1
Ensembl
ENSG00000155096
Chromosome
8
Canonical length
448 aa
Protein class
Predicted intracellular proteins
Subcellular location
Nucleoli,Nucleoli rim

OverviewNCBI Gene

The protein encoded by this gene belongs to the antizyme inhibitor family, which plays a role in cell growth and proliferation by maintaining polyamine homeostasis within the cell. Antizyme inhibitors are homologs of ornithine decarboxylase (ODC, the key enzyme in polyamine biosynthesis) that have lost the ability to decarboxylase ornithine; however, retain the ability to bind to antizymes. Antizymes negatively regulate intracellular polyamine levels by binding to ODC and targeting it for degradation, as well as by inhibiting polyamine uptake. Antizyme inhibitors function as positive regulators of polyamine levels by sequestering antizymes and neutralizing their effect. This gene encodes antizyme inhibitor 1, the first member of this gene family that is ubiquitously expressed, and is localized in the nucleus and cytoplasm. Overexpression of antizyme inhibitor 1 gene has been associated with increased proliferation, cellular transformation and tumorigenesis. Gene knockout studies showed that homozygous mutant mice lacking functional antizyme inhibitor 1 gene died at birth with abnormal liver morphology. RNA editing of this gene, predominantly in the liver tissue, has been linked to the progression of hepatocellular carcinoma. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2014]

Canonical amino-acid sequenceUniProt

448 residues, UniProt reviewed canonical sequence.

>O14977|AZIN1
     1  MKGFIDDANY SVGLLDEGTN LGNVIDNYVY EHTLTGKNAF FVGDLGKIVK KHSQWQNVVA
    61  QIKPFYTVKC NSAPAVLEIL AALGTGFACS SKNEMALVQE LGVPPENIIY ISPCKQVSQI
   121  KYAAKVGVNI LTCDNEIELK KIARNHPNAK VLLHIATEDN IGGEEGNMKF GTTLKNCRHL
   181  LECAKELDVQ IIGVKFHVSS ACKESQVYVH ALSDARCVFD MAGEIGFTMN MLDIGGGFTG
   241  TEFQLEEVNH VISPLLDIYF PEGSGVKIIS EPGSYYVSSA FTLAVNIIAK KVVENDKFPS
   301  GVEKTGSDEP AFMYYMNDGV YGSFASKLSE DLNTIPEVHK KYKEDEPLFT SSLWGPSCDE
   361  LDQIVESCLL PELNVGDWLI FDNMGADSFH EPSAFNDFQR PAIYYMMSFS DWYEMQDAGI
   421  TSDSMMKNFF FVPSCIQLSQ EDSFSAEA

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against AZIN1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
127 nTPM

Expression across tissuesHPA

Tissue

  • pancreas: 127 nTPM
  • bone marrow: 124 nTPM
  • cerebral cortex: 77 nTPM
  • placenta: 76 nTPM
  • small intestine: 75 nTPM
  • liver: 71 nTPM

Single-cell type

  • neutrophils: 990 nCPM
  • syncytiotrophoblasts: 449 nCPM
  • neutrophil progenitors: 316 nCPM
  • monocytes: 275 nCPM
  • respiratory ciliated cells: 248 nCPM
  • cardiomyocytes: 247 nCPM

Immune cell

  • basophil: 73 nTPM
  • neutrophil: 70 nTPM
  • eosinophil: 69 nTPM
  • total PBMC: 67 nTPM
  • non-classical monocyte: 66 nTPM
  • intermediate monocyte: 65 nTPM

Brain region

  • white matter: 118 nTPM
  • spinal cord: 100 nTPM
  • hypothalamus: 96 nTPM
  • cerebral cortex: 95 nTPM
  • basal ganglia: 92 nTPM
  • midbrain: 90 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.24
gnomAD pLI
0.99
gnomAD missense Z
1.8
DepMap mean gene effect
-0.13
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 16% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of AZIN1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads AZIN1 as an antibody target. Whether an autoantibody or antibody against AZIN1 could matter depends on whether native AZIN1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

AZIN1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label AZIN1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/AZIN1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...